Eyepoint Pharmaceuticals (NASDAQ:EYPT) focuses on developing and commercializing therapeutics for eye diseases. Specializing in sustained release drug delivery products, this company is dedicated to advancing treatments for serious eye disorders. Their project portfolio includes innovative technologies aimed at improving the lives of patients with chronic eye conditions. Eyepoint Pharmaceuticals is actively engaged in research, development, and commercialization stages to bring its unique products to market. The company's objectives are centered on achieving excellence in eye care, expanding their product offerings, and reaching a broader patient population.